
This observation does not impact continuity of the business and the company would continue its manufacturing activities in current good manufacturing practice (cGMP) compliant manner, JB Chemicals and Pharmaceuticals said . The company proposes to address this observation in the next 15 days.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39nBAZu
via
IFTTT
0 comments:
Post a Comment